Clinical Trial Detail

NCT ID NCT03144245
Title Study of AMV564 in Patients With AML
Recruitment Active, not recruiting
Gender both
Phase Phase I
Variant Requirements No
Sponsors Amphivena Therapeutics, Inc.
Indications

acute myeloid leukemia

Therapies

AMV-564

Age Groups: adult senior

No variant requirements are available.